Diageo 6-K: Equity & Reserves Update for H1 2024

TL;DR

**Diageo just dropped its half-year financial update, showing its equity and reserves.**

AI Summary

Diageo PLC filed a 6-K report for the period ending December 31, 2023, providing an update on its financial position. This filing includes details on the company's equity attributable to owners of the parent, non-controlling interests, and various reserve accounts like issued capital, share premium, and retained earnings. For investors, this matters because it offers a snapshot of Diageo's financial health and how its equity structure has evolved over the past six months, which can influence future dividend policies and share buybacks.

Why It Matters

This filing provides a transparent look into Diageo's balance sheet, helping investors understand the company's financial stability and how shareholder equity is structured.

Risk Assessment

Risk Level: low — This 6-K filing is a routine financial update and does not indicate any immediate new risks or significant changes to the company's operations.

Analyst Insight

A smart investor would review the detailed financial statements, once available, to understand the specific changes in Diageo's equity and reserves and assess their impact on the company's overall financial health and future outlook.

Key Players & Entities

• DIAGEO PLC (company) — the company filing the 6-K
• December 31, 2023 (date) — the end of the reporting period for the 6-K
• June 30, 2023 (date) — the previous fiscal year-end for comparison
• June 30 (date) — Diageo's fiscal year end

FAQ

Key Financial Figures

• $1.0 billion — on 31 July 2023, seeks to return up to $1.0 billion to shareholders and is expected to be
• $0.6 billion — mme that ended on 2 June 2023, in which $0.6 billion of capital (announced as up to 0.5 bil
• $480 million — res (2022 – 14.8 million ) at a cost of $480 million (including transaction costs of $2 mil
• $2 million — illion (including transaction costs of $2 million ) (2022 – $655 million including transa
• $655 million — ansaction costs of $2 million ) (2022 – $655 million including transaction costs of $8 milli
• $8 million — million including transaction costs of $8 million). All shares purchased under the share
• $522 million — ed. The remaining contractual amount of $522 million is expected to be purchased by 26 June
• $497 million — osed periods, a financial liability of $497 million (including transaction costs) was accru
• $259 million — tual terms at 31 December 2023 (2022 – $259 million) equivalent to 13.6 million shares (202
• $11.0 billion — ncial highlights Reported net sales of $11.0 billion declined 1.4% or $158 million, due to a
• $158 m — sales of $11.0 billion declined 1.4% or $158 million, due to a $167 million unfavourab
• $167 million — declined 1.4% or $158 million, due to a $167 million unfavourable foreign exchange impact a
• $67 million — act and an organic net sales decline of $67 million or 0.6%, driven by a $310 million or 23
• $310 million — ine of $67 million or 0.6%, driven by a $310 million or 23% decline in Latin America and Ca
• $72 million — impact of LAC, reported net sales grew $72 million or 0.7%, and organic net sales grew $24

Filing Documents

• deo-20231231.htm (6-K) — 4940KB
• deo-20231231_g1.jpg (GRAPHIC) — 1KB
• deo-20231231_g10.gif (GRAPHIC) — 20KB
• deo-20231231_g11.gif (GRAPHIC) — 30KB
• deo-20231231_g12.gif (GRAPHIC) — 20KB
• deo-20231231_g13.gif (GRAPHIC) — 25KB
• deo-20231231_g14.gif (GRAPHIC) — 20KB
• deo-20231231_g15.gif (GRAPHIC) — 27KB
• deo-20231231_g16.gif (GRAPHIC) — 20KB
• deo-20231231_g17.gif (GRAPHIC) — 14KB
• deo-20231231_g18.gif (GRAPHIC) — 14KB
• deo-20231231_g19.gif (GRAPHIC) — 15KB
• deo-20231231_g2.gif (GRAPHIC) — 59KB
• deo-20231231_g3.gif (GRAPHIC) — 66KB
• deo-20231231_g4.gif (GRAPHIC) — 81KB
• deo-20231231_g5.gif (GRAPHIC) — 103KB
• deo-20231231_g6.gif (GRAPHIC) — 130KB
• deo-20231231_g7.gif (GRAPHIC) — 22KB
• deo-20231231_g8.gif (GRAPHIC) — 19KB
• deo-20231231_g9.gif (GRAPHIC) — 31KB
• 0000835403-24-000006.txt ( ) — 15874KB
• deo-20231231.xsd (EX-101.SCH) — 83KB
• deo-20231231_cal.xml (EX-101.CAL) — 125KB
• deo-20231231_def.xml (EX-101.DEF) — 295KB
• deo-20231231_lab.xml (EX-101.LAB) — 717KB
• deo-20231231_pre.xml (EX-101.PRE) — 441KB
• deo-20231231_htm.xml (XML) — 2615KB

financial statements for the year ended 30 June 2023, which were prepared in accordance with IFRS Accounting Standards

financial statements for the year ended 30 June 2023, which were prepared in accordance with IFRS Accounting Standards adopted by the UK and IFRS Accounting Standards issued by IASB, including interpretations issued by the IFRS Interpretations Committee. IFRS Accounting Standards as adopted by the UK differs in certain respects from IFRS Accounting Standards as issued by the IASB, but the differences have no impact on the group's consolidated financial statements for the periods presented. The consolidated financial statements are prepared on a going concern basis under the historical cost convention, unless stated otherwise. In preparing these condensed consolidated interim financial statements, the significant judgements made by management when applying the group's accounting policies and the significant areas where estimates were required were the same as those that applied to the consolidated financial statements for the year ended 30 June 2023, with the exception of changes in estimates disclosed in note 3 Exceptional items and note 12 Contingent liabilities and legal proceedings. These condensed consolidated interim financial statements were approved for issue on 29 January 2024. The financial statements for Diageo plc for the year ending 30 June 2024 will be prepared in accordance with IFRS Accounting Standards as adopted by the UK and IFRS Accounting Standards as issued by the IASB, including interpretations issued by the IFRS Interpretations Committee. The business review and financial information included in this document for the six months ended 31 December 2023 and 31 December 2022 have been derived from the Diageo interim condensed consolidated financial information. The principal executive office of the company is located at 16 Great Marlborough Street, London W1F 7HS, England and its telephone number is +44 (0) 20 7947 9100. Table of Contents 3 MARKET DATA The market data and competitive set classifications are taken from inde

View Full Filing

View this 6-K filing on SEC EDGAR